Spot Trading’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$32.6M Buy
401,976
+202,237
+101% +$15.5M 0.56% 9
2017
Q2
$14.1M Buy
199,739
+113,702
+132% +$7.57M 0.28% 36
2017
Q1
$5.84M Sell
86,037
-86,921
-50% -$6.11M 0.19% 73
2016
Q4
$12.4M Buy
+172,958
New +$12.9M 0.29% 46
2016
Q3
Sell
-63,751
Closed -$5.18M 3218
2016
Q2
$5.32M Sell
63,751
-37,565
-37% -$3.33M 0.09% 284
2016
Q1
$9.31M Buy
101,316
+32,505
+47% +$2.93M 0.16% 140
2015
Q4
$6.96M Buy
68,811
+9,117
+15% +$949K 0.07% 362
2015
Q3
$5.86M Buy
59,694
+59,529
+36,078% +$6.61M 0.06% 430
2015
Q2
$19K Buy
165
+140
+560% +$15.3K ﹤0.01% 3473
2015
Q1
$2K Sell
25
-267,552
-100% -$27.2M ﹤0.01% 3733
2014
Q4
$25.2M Buy
267,577
+80,182
+43% +$8.29M 0.16% 116
2014
Q3
$19.9M Buy
187,395
+151,018
+415% +$14.8M 0.1% 234
2014
Q2
$3.02M Sell
36,377
-113,872
-76% -$8.86M 0.01% 1315
2014
Q1
$10.6M Sell
150,249
-147,803
-50% -$11.6M 0.06% 420
2013
Q4
$22.4M Buy
298,052
+56,507
+23% +$3.93M 0.12% 158
2013
Q3
$15.2M Sell
241,545
-40,325
-14% -$2.41M 0.09% 211
2013
Q2
$14.5M Buy
+281,870
New +$14.7M 0.09% 217

Other funds holding GILD

Spot Trading's GILD Position: Q3 2017 in Review

Spot Trading increased its Gilead Sciences (GILD) stake by 101% in Q3 2017, buying an estimated $15.5M and bringing the position to 401,976 shares worth $32.6M. The position accounts for 0.56% of the portfolio, ranked #9.

Spot Trading first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Spot Trading held 401,976 shares of Gilead Sciences worth $32.6M as of Q3 2017.
  • Spot Trading bought 202,237 Gilead Sciences shares in Q3 2017, an estimated $15.5M.
  • Gilead Sciences made up 0.56% of Spot Trading's portfolio in Q3 2017, its #9 holding.
  • Spot Trading first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.